Epic Research

Wednesday, April 9, 2014

Epic Research Update : Bayer Crop / Natco Pharma

Bayer versus Natco Case: Bayer to Bombay High Court

Natco did not meet preconditions for compulsory license

Bayer challenged IPAB order granting compulsory license to Natco

IPAB granted compulsory license for cancer drug Nexavar

IPAB is Intellectual Property Appellate Board -’Reasonable price’ for sale of Nexavar not specified

Open to few days of free supply in monthly dosages

Spent billions on research for drugs, need to recover through sales

For more information ✆ - 0731-6642300 or Visit https://www.epicresearch.co/

No comments:

Post a Comment